Serum calcium and the calcium-sensing receptor polymorphism rs17251221 in relation to coronary heart disease, type 2 diabetes, cancer and mortality: the Tromsø Study.
about
Genetic polymorphisms of CASR and cancer risk: evidence from meta-analysis and HuGE reviewNew functional aspects of the extracellular calcium-sensing receptorCalcium-Sensing Receptor in Breast Physiology and CancerCalcium and phosphate concentrations and future development of type 2 diabetes: the Insulin Resistance Atherosclerosis StudyThe Rotterdam Study: 2016 objectives and design update.Calcium intake, polymorphisms of the calcium-sensing receptor, and recurrent/aggressive prostate cancer.Serum Calcium and Risk of Nonmedullary Thyroid Cancer in Patients with Primary Hyperparathyroidism.Early origins of chronic obstructive lung diseases across the life course.Circulating calcium concentrations, vascular disease and mortality: a systematic review.Serum calcium and incident type 2 diabetes: the Atherosclerosis Risk in Communities (ARIC) study.Burden of Cancer in a Large Consortium of Prospective Cohorts in Europe.Serum calcium and incident diabetes: an observational study and meta-analysis.The Generation R Study: Biobank update 2015.A genetic variant (rs17251221) in the calcium-sensing receptor relates to hepatocellular carcinoma susceptibility and clinical outcome treated by transcatheter hepatic arterial chemoembolization (TACE) therapy.Seasonal Variation of Blood Calcium Levels in Children Aged 1-10.Association of bone metabolism markers with coronary atherosclerosis and coronary artery disease in postmenopausal women.Associations of serum calcium levels and dietary calcium intake with incident type 2 diabetes over 10 years: the Korean Genome and Epidemiology Study (KoGES).Effect of exercise on bone in poorly controlled type 1 diabetes mediated by the ActRIIB/Smad signaling pathway
P2860
Q26765295-BC574CB2-9AE2-4626-A7C3-40729C0C9E33Q26825557-8AF181CC-6107-42E9-BE21-A6CA333D3AA7Q28071486-A89278A2-5723-428F-85D3-62FEDC76D403Q33994155-8F84C785-AE58-4C54-B896-6AEF242FE6C2Q36084114-80F5B4F3-6326-4F8E-96B0-4B32D9BAC08EQ36248798-3408C3AF-FFCD-4A89-BE4E-044DFEB1EF64Q37450053-F1571505-81E6-435F-9E09-1104D63A49DDQ38299379-3EBA4AC2-6D76-4E9C-979B-15B263147846Q38691493-41035341-975C-4F84-ADD1-024BE8762FA3Q40627550-266C1814-EED3-422A-951F-D47017354EDCQ40765309-C2AA6527-8FCC-414F-BC10-3DA7E9050D90Q41056825-8165E12F-2D93-4DCE-A684-1707503C07B8Q41665622-572D6201-24FE-4B39-8198-F1251A15583FQ44048380-0668C709-1654-4720-93DB-84F38A29F26AQ54383851-A92D7ECF-66A9-4B36-B7B1-4666FD471AE4Q54476019-5B154AB2-8D3F-4842-81C0-C39895081CD0Q55386815-4CC20AEB-F9BF-4E17-A480-8A52140FA6A4Q58784211-5C2D0D47-AA11-4B86-AE94-45BB73F1F999
P2860
Serum calcium and the calcium-sensing receptor polymorphism rs17251221 in relation to coronary heart disease, type 2 diabetes, cancer and mortality: the Tromsø Study.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Serum calcium and the calcium- ...... d mortality: the Tromsø Study.
@en
Serum calcium and the calcium- ...... d mortality: the Tromsø Study.
@nl
type
label
Serum calcium and the calcium- ...... d mortality: the Tromsø Study.
@en
Serum calcium and the calcium- ...... d mortality: the Tromsø Study.
@nl
prefLabel
Serum calcium and the calcium- ...... d mortality: the Tromsø Study.
@en
Serum calcium and the calcium- ...... d mortality: the Tromsø Study.
@nl
P2093
P2860
P50
P1476
Serum calcium and the calcium- ...... d mortality: the Tromsø Study.
@en
P2093
Ellisiv Bøgeberg Mathiesen
Guri Grimnes
Rolf Jorde
Yngve Figenschau
P2860
P2888
P304
P356
10.1007/S10654-013-9822-Y
P577
2013-07-17T00:00:00Z